Deja Vi This stock keeps drifting lower, over95% from peak, with dilution ongoing... Why???
After years and years of awaiting new versions of this product, stories of thousands of leads that are materializing 100% into sales,NICE guaranteed , Sales teams, China’s sales, GE alliance and tens of thousands of distributors, once again the idea of putting these machines out into KL‘s is being put for. Meanwhile, the sales have never materialized always being in the order of 30 to 80,000 per year, on costs numbering in the millions.
The last financing still hasn’t closed, telling me that the street is not interested. Going now to retail investors to see if they can keep this going. We will see what happens waiting waiting waiting.
If this is the standard of care-why isn’t anyone ordering it and why isn’t the cardiology literature saying this?
Just being stated here by jopatchie and other promoters imo
For the record ie. from Sedar:
Total revenue for year ending Dec. 31, 2018 = $60,177
Total revenue for year ending Dec. 31, 2019 = $81,023
Total revenue for year ending Dec. 31, 2020 = $36,017
Total revenue for year ending Dec. 31, 2021 = $Nil
Total revenue for year ending Dec. 31, 2022 68,167
Total revenue for year ending Dec. 31, 2023
Revenue to date ~ 30000
All in my opinion, do your own due diligence. Don’t trust what you read on this board